Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
41,630
Total Claims
$3.9M
Drug Cost
989
Beneficiaries
$3,941
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-41%
Opioid rate vs peers
1.5% vs 2.6% avg
+219%
Cost per patient vs peers
$3,941 vs $1,237 avg
+105%
Brand preference vs peers
18.8% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.5%
Opioid Rate
632
Opioid Claims
$24K
Opioid Cost
16.1%
Long-Acting Rate
Brand vs Generic
Brand: 7,839 claims · $2.8M
Generic: 33,761 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,394 | $411K |
| Rifaximin | 138 | $209K |
| Pimavanserin Tartrate | 72 | $197K |
| Eslicarbazepine Acetate | 279 | $181K |
| Rivaroxaban | 487 | $137K |
| Deutetrabenazine | 37 | $123K |
| Valbenazine Tosylate | 15 | $120K |
| Linaclotide | 196 | $105K |
| Dulaglutide | 144 | $88K |
| Sacubitril/Valsartan | 278 | $85K |
| Insulin Aspart | 371 | $61K |
| Mirabegron | 234 | $57K |
| Memantine Hcl | 668 | $56K |
| Paliperidone Palmitate | 19 | $55K |
| Dextromethorphan Hbr/Quinidine | 78 | $49K |
Prescribing Profile
Patient Profile
79
Avg Age
66%
Female
2.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About